Hou T - Search Results

1

The prognostic value of tumor mutation burden in EGFR-mutant advanced lung adenocarcinoma, an analysis based on cBioPortal data base.

Jiao XD, He X, Qin BD, Liu K, Wu Y, Liu J, Hou T, Zang YS. Jiao XD, et al. Among authors: hou t. J Thorac Dis. 2019 Nov;11(11):4507-4515. doi: 10.21037/jtd.2019.11.04. J Thorac Dis. 2019. PMID: 31903239 Free PMC article.

2

Tumor mutation burden in Chinese cancer patients and the underlying driving pathways of high tumor mutation burden across different cancer types.

Jiao XD, Zhang XC, Qin BD, Liu D, Liu L, Ni JJ, Ning ZY, Chen LX, Zhu LJ, Qin SB, Ying SP, Chen XQ, Li AJ, Hou T, Han-Zhang H, Ye J, Zheng J, Chuai S, Zang YS. Jiao XD, et al. Among authors: hou t. Ann Transl Med. 2020 Jul;8(14):860. doi: 10.21037/atm-20-3807. Ann Transl Med. 2020. PMID: 32793704 Free PMC article.

3

Clinical and molecular feature-based nomogram model for predicting benefit from bevacizumab combined with first-generation EGFR-tyrosine kinase inhibitor (TKI) in EGFR-mutant advanced NSCLC.

Zhang Y, Zeng L, Zhang X, Li Y, Liu L, Xu Q, Yang H, Jiang W, Lizaso A, Qiu L, Hou T, Liu J, Peng L, Yang N. Zhang Y, et al. Among authors: hou t. BMC Med. 2021 Oct 19;19(1):245. doi: 10.1186/s12916-021-02118-x. BMC Med. 2021. PMID: 34663309 Free PMC article.

4

Perioperative Circulating Tumor DNA in Colorectal Liver Metastases: Concordance with Metastatic Tissue and Predictive Value for Tumor Burden and Prognosis.

He Y, Ma X, Chen K, Liu F, Cai S, Han-Zhang H, Hou T, Xiang J, Peng J. He Y, et al. Among authors: hou t. Cancer Manag Res. 2020 Mar 4;12:1621-1630. doi: 10.2147/CMAR.S240869. eCollection 2020. Cancer Manag Res. 2020. PMID: 32184665 Free PMC article.

5

Tumor mutation burden derived from small next generation sequencing targeted gene panel as an initial screening method.

Tang Y, Li Y, Wang W, Lizaso A, Hou T, Jiang L, Huang M. Tang Y, et al. Among authors: hou t. Transl Lung Cancer Res. 2020 Feb;9(1):71-81. doi: 10.21037/tlcr.2019.12.27. Transl Lung Cancer Res. 2020. PMID: 32206555 Free PMC article.

6

Investigation on the potential of circulating tumor DNA methylation patterns as prognostic biomarkers for lung squamous cell carcinoma.

Liu Y, Feng Y, Hou T, Lizaso A, Xu F, Xing P, Wang H, Kang Q, Zhang L, Shi Y, Hu X. Liu Y, et al. Among authors: hou t. Transl Lung Cancer Res. 2020 Dec;9(6):2356-2366. doi: 10.21037/tlcr-20-1070. Transl Lung Cancer Res. 2020. PMID: 33489798 Free PMC article.

7

A comprehensive pan-cancer analysis of CD274 gene amplification, tumor mutation burden, microsatellite instability, and PD-L1 expression in Chinese cancer patients.

Gao G, Zhang XD, Qu H, Yao B, Zhou Y, Xiang J, Chen C, Hou T, Chen K, Xu J. Gao G, et al. Among authors: hou t. Ann Transl Med. 2021 Apr;9(8):677. doi: 10.21037/atm-21-853. Ann Transl Med. 2021. PMID: 33987375 Free PMC article.

8

Potential utility of longitudinal somatic mutation and methylation profiling for predicting molecular residual disease in postoperative non-small cell lung cancer patients.

Li H, Ma ZL, Li B, Pan YJ, Xiang JQ, Zhang YW, Sun YH, Hou T, Lizaso A, Chen Y, Li X, Hu H. Li H, et al. Among authors: hou t. Cancer Med. 2021 Dec;10(23):8377-8386. doi: 10.1002/cam4.4339. Epub 2021 Oct 19. Cancer Med. 2021. PMID: 34664796 Free PMC article.

9

Characterization of frequently mutated cancer genes in Chinese breast tumors: a comparison of Chinese and TCGA cohorts.

Zhang G, Wang Y, Chen B, Guo L, Cao L, Ren C, Wen L, Li K, Jia M, Li C, Mok H, Chen X, Wei G, Lin J, Zhang Z, Hou T, Han-Zhang H, Liu C, Liu H, Liu J, Balch CM, Meric-Bernstam F, Liao N. Zhang G, et al. Among authors: hou t. Ann Transl Med. 2019 Apr;7(8):179. doi: 10.21037/atm.2019.04.23. Ann Transl Med. 2019. PMID: 31168460 Free PMC article.

10

Heterogeneity of genomic profile in patients with HER2-positive breast cancer.

Chen B, Zhang G, Wei G, Wang Y, Guo L, Lin J, Li K, Mok H, Cao L, Ren C, Wen L, Jia M, Li C, Hou T, Han-Zhang H, Liu J, Balch CM, Liao N. Chen B, et al. Among authors: hou t. Endocr Relat Cancer. 2020 Mar;27(3):153-162. doi: 10.1530/ERC-19-0414. Endocr Relat Cancer. 2020. PMID: 31905165

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,183 results

Search Page

Filters